Across TCGA pan-cancer cohorts, LINC00242 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated LINC00242 data layer compared with 1 for mutation status.
The strongest signal is observed in uterine carcinosarcoma (UCS), where higher LINC00242 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC00242 expression acts as an unfavorable survival marker, although some lineages such as UCS and PAAD show a favorable association.
UCS, ACC, and PAAD are the cancer types where LINC00242 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.